NVEC · NVE Corporation · Stock research

Current Thesis

NVE reported the quarter ended 2026-06-30 on 2026-07-22: revenue $11.034M against $6.100M a year earlier (+81%), product sales $10.7M (+82%), net income $6.39M, diluted EPS $1.32 versus $0.74. Gross margin came in at 81.3% of revenue and operating margin at 66% (Q1 FY2027 call, 2026-07-22). The stock traded +52.4% intraday to $132.07 the following session (Benzinga, 2026-07-23).

The narrative leg an investor is buying is a step-change in demand for spintronic sensors and couplers — management pointed to existing customers adopting newer products inside "a strong semiconductor market," with robotics and AI applications cited on the call. That claim sits against a company whose FY2026 revenue was $26.33M, up 1.76% over FY2025's $25.87M (stockanalysis.com, 2026-08-08). One quarter has broken a two-year flat line. Nothing yet confirms it repeats: management declined to give guidance and there is no meaningful sell-side estimate to anchor against.

Bullish and bearish views on NVE Corporation

The model's bull view on NVE Corporation (NVEC), in brief: Revenue for the quarter ended 2026-06-30 rose 81% to $11.034M from $6.100M; product sales +82%, contract R&D +53% (release, 2026-07-22). The bear view: The entire re-rating rests on one observation. Both cases follow in full.

Bull Case

• Revenue for the quarter ended 2026-06-30 rose 81% to $11.034M from $6.100M; product sales +82%, contract R&D +53% (release, 2026-07-22).
• Operating leverage is unusual for the size: 81.3% gross margin, 66% operating margin in the June quarter (Q1 FY2027 call, 2026-07-22). Incremental revenue converts to profit at a rate few analog suppliers reach.
• Net income $6.39M (+79%), diluted EPS $1.32 vs $0.74 (release, 2026-07-22).
• TTM revenue has moved to $31.26M, +24.1%, against a FY2026 full year of $26.33M (stockanalysis.com, 2026-08-08) — the trailing line has begun to bend, not just one quarter's print.
• Product vector with multi-year device cycles: two wafer-level chip-scale sensors for implantable medical devices, roughly one-third the area of the conventionally packaged versions and stable in magnetic fields above 9 Tesla (call, 2026-07-22). Implant design wins, once qualified, are sticky.
• Capital return did not pause through the inflection: $1.00 per share quarterly dividend declared 2026-07-22, payable 2026-08-31 to holders of record 2026-08-03 — $4.00 annualized, a 3.18% yield (stockanalysis.com, 2026-08-08).

Bear Case

• The entire re-rating rests on one observation. Management gave no revenue or EPS guidance, offering only that they were "very optimistic and extremely pleased" (call, 2026-07-22). Nothing quantifies whether $11.0M is a quarterly run-rate.
• Order concentration is implied by management's own framing: "most of the volume was in existing customers," while new customers "don't move the top line an awful lot" (call, 2026-07-22). A narrow account base can reverse in a single quarter on distributor ordering patterns.
• The base rate argues for caution: FY2026 revenue grew 1.76% to $26.33M (stockanalysis.com, 2026-08-08). NVE's revenue history is lumpy, and the June quarter is far above the FY2026 average quarterly rate.
• Valuation already discounts continuation — market cap $609.19M and a 33.85 P/E on 4.84M shares outstanding (stockanalysis.com, 2026-08-08) for a business that did $26.33M of revenue last fiscal year.
• No sell-side estimate channel means no institutional anchor; price discovery in this name is flow-driven, which is what a +52.4% single session on 4.84M shares looks like (2026-07-23).
• The 2026-07-23 gap is unfilled. That session printed $105.00 in pre-market (+21.1%) before reaching $132.07 intraday (Benzinga, 2026-07-23), leaving a wide unrepaired zone beneath the current range.
• Isolation and magnetic sensing are contested by far larger process owners — Analog Devices, Broadcom and Silicon Labs in digital isolators, Allegro, TDK and Infineon in magnetic sensing. An 81.3% gross margin invites attack.

Setup & Price Structure

• Last completed daily close $125.94 (2026-08-07), 52-week high $133.06, so the name sits 5.4% below its high with a three-month return of +42.4% and RSI(14) at 71.6.
• Behaviour since the print is the constructive part: after the 2026-07-23 session peaked at $132.07, price has held near the high through 2026-08-07 rather than retracing into the gap. Two weeks of range-holding after a 50%+ repricing is absorption rather than distribution, though the sample is short.
• Overhead reference: $132.07 (2026-07-23 intraday) and the $133.06 52-week high. The nearest observable shelf below is $105.00, the level the stock printed in the 2026-07-23 pre-market session before the gap extended. Between $105 and the current range there is no established volume structure.
• Life-cycle: ACCELERATING. Dating it: the 2026-07-22 print, three separate Benzinga movers items on 2026-07-23, inclusion in Benzinga's "Stock Whisper" index on 2026-08-01, and price within 5.4% of the 52-week high on 2026-08-07. Attention here is new. The qualifier is that with no meaningful analyst coverage, acceleration has no estimate-revision channel to run through — the bid has to come from discretionary and retail flow.
• Crowding and positioning observables, stated without a verdict: RSI(14) 71.6 (2026-08-07); +42.4% over three months; retail-sentiment aggregator coverage clustering on 2026-08-01; no earnings date inside the next 30 days to compress positioning; no Form 4 or other filings surfaced in the trailing 30-day window; the dividend record date passed 2026-08-03, so shares already trade ex the August payment.

Catalyst Calendar (next 30 days)

• 2026-08-31 — $1.00 per share quarterly dividend payable, record date 2026-08-03. A cash event; it carries no new information about demand, and the record date is already behind the tape.
• ~2026-10-21 (est.) — Q2 FY2027 results for the quarter ending 2026-09-30. Outside the 30-day window. This is the first observation that tests the June quarter, and there is no scheduled company event before it.
• No confirmed conference appearances, product launches or regulatory dates fall inside the window. The next 30 days are an information vacuum for this name.

What Would Change Our Mind

Durability is the single point of failure. The re-rating capitalizes one quarter of $11.034M revenue against a FY2026 base of $26.33M that grew 1.76%. A Q2 FY2027 print (~2026-10-21 est.) showing product sales materially below the $10.7M June-quarter level would recast June as a distributor pull-forward and remove the basis for the multiple, regardless of where price sits at the time.

On structure, a weekly close below $105 gives up the shelf where the 2026-07-23 gap opened and would mark the inflection leg as failed; the zone between there and the current range has no volume history to arrest a decline.

A gross margin printing below 78% in a subsequent quarter would suggest the 81.3% June figure reflected mix rather than pricing power. An insider Form 4 showing sales into this range would be an observable that the informed side is monetizing the re-rating. And if retail-aggregator coverage keeps clustering while the range stops making higher highs above $133.06 through September, the theme has moved toward SATURATED without the fundamentals confirming.

Correlation Notes

• Closest listed reference points are Allegro MicroSystems in magnetic sensing and Analog Devices and Silicon Labs in digital isolation, where NVE's spintronic couplers compete with optocoupler and capacitive-isolator incumbents. The analog/industrial semiconductor cycle sets the backdrop management described as "a strong semiconductor market" (call, 2026-07-22).
• The implantable-device exposure ties part of demand to medical OEM volumes — pacing and neuromodulation build rates — a cycle that runs independently of AI capex and can offset or mask a robotics-driven quarter.
• With 4.84M shares outstanding (2026-08-08), the name is a liquidity outlier. Single-session moves above 20% are inside its realized behaviour (2026-07-23), and small-cap and index flows can dominate fundamentals on any given day in both directions.
• The $4.00 annualized dividend gives NVEC a rate-sensitive holder base that pure micro-cap growth names lack. Yield holders and momentum holders exit on different signals, which can make the tape discontinuous around dividend and earnings dates.